Form D · Biotechnology
PROTEON THERAPEUTICS INC
Waltham, MA · CIK 0001359931
Offering snapshot reported Aug 16, 2017 · SEC filing
- Reported sold
- $22M Offering amount: $22M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 16, 2017 | Initial | $22,000,000 | No comparison | 11 | SEC filing |
| May 28, 2014 | Initial | $29,565,934 | No comparison | 22 | SEC filing |
| Feb 19, 2014 | Initial | $4,338,660 | No comparison | 17 | SEC filing |
| Aug 11, 2011 | Initial | $15,183,371 | No comparison | 19 | SEC filing |
| Mar 11, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 4, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 14, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292913
Series A Convertible Preferred Stock which is convertible into Common Stock, $.001 par value.
Source: Form D, filed Aug 16, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hubert Birner | Director |
| Hubert Birner, Ph. D. | Director |
| Garen Bohlin | Director |
| Steven K. Burke | Executive |
| Steven K. Burke, M.D. | Executive |
| Scott A. Canute | Director |
| George A. Eldridge | Executive |
| Todd Foley | Director |
| F. Nicholas Franano | Director |
| John G. Freund | Director |
| John G. Freund, M.D. | Director |
| Daniel P. Gottlieb | Executive |
| Tim Haines | Director |
| Paul J. Hastings | Director |
| Stephen Hoffman | Director |
| Tony Kingsley | Director |
| Dmitry Kobyzev | Director |
| Matthew P. Kowalsky | Executive |
| Jonathan Leff | Director |
| David G. Lowe | Director |
| Timothy P. Noyes | Director, Executive |
| Brendan O'leary | Director |
| Gregory D. Phelps | Director |
| Dean Profis | Executive |
| Steven St. Peter | Director |
| E. Scott Toner | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 West Street
Waltham, MA, 02451
Waltham, MA, 02451